Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2020

Feb 26, 2020

29831_dirs_2020-02-25_418eb0d2-2cca-4210-ba4c-433d37800cff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-23

Reporting Person: GOETTLER MICHAEL (Group President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-23 Common Stock F 2116.0000 $35.7200 Disposed 25428.0000 Direct

Footnotes

F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

F2: Price is the closing price of Pfizer common stock on February 21, 2020.